Pregnancy can bring or worsen anxiety and depression, but stopping treatment suddenly may also create risks. The safest choice depends on the medicine, dose, pregnancy stage, and the person’s mental health history.
Doctors often consider certain SSRIs, such as sertraline, when the benefits outweigh possible risks; benzodiazepines usually require extra caution because they may affect the newborn. A prenatal care provider and mental health professional can compare options, adjust treatment, and discuss therapy or other support.
This guide explains which medicines may be considered, why some need caution, and how treatment plans can change during pregnancy. It also covers questions to ask the care team and practical non-medication support.
Key Takeaways
- Some antidepressants may be used during pregnancy under medical supervision.
- Benzodiazepines and certain medicines may need extra caution.
- Therapy, healthy routines, and prenatal care can support medication treatment.
How Pregnancy Can Affect Mental Health Treatment
Pregnancy can change medication needs, side effects, and treatment goals. Clinicians weigh the risks of untreated illness against possible effects on fetal development and plan care for both the pregnant patient and baby.
Risks of Untreated Anxiety and Depression
Untreated anxiety or depression can affect sleep, nutrition, daily functioning, and prenatal care. Severe symptoms may also raise the risk of substance use, self-harm, missed appointments, preterm birth, or low birth weight. These risks depend on the illness, its severity, and the patient’s overall health.
Stopping medication suddenly can cause withdrawal symptoms or a return of depression or anxiety. A relapse may become harder to treat during pregnancy and after delivery. Patients should not stop, lower, or switch medication without medical guidance.
Treatment may include therapy, regular check-ins, sleep and activity support, and medication when needed. A clinician can screen for worsening symptoms and create a safety plan, especially if the patient has thoughts of self-harm.
Balancing Maternal and Fetal Health
No medication has zero risk, but many commonly used antidepressants have reassuring pregnancy data. Selective serotonin reuptake inhibitors, including sertraline, fluoxetine, and citalopram, may be options for some patients. Bupropion and certain serotonin-norepinephrine reuptake inhibitors may also be considered. The best choice depends on past treatment response, dose, other medicines, and pregnancy history.
| Treatment decision | Factors clinicians may consider |
|---|---|
| Continue current medication | Symptom control, relapse history, dose, and available safety data |
| Start medication | Illness severity, therapy response, and risks of delayed treatment |
| Change or taper medication | Side effects, limited benefit, or a safer effective alternative |
| Plan for delivery | Possible newborn adaptation symptoms and monitoring needs |
Some babies exposed to antidepressants late in pregnancy may have short-term symptoms such as jitteriness, feeding problems, or breathing difficulty. Clinicians consider these effects alongside the risks of untreated illness and avoid abrupt medication changes.
Medication Classes Commonly Considered
Medication choices during pregnancy depend on the person’s symptoms, treatment history, pregnancy stage, and other health needs. Doctors often consider SSRIs first, while SNRIs and other antidepressants may suit specific situations.
Selective Serotonin Reuptake Inhibitors
SSRIs commonly treat both depression and anxiety during pregnancy. Frequently considered options include sertraline, escitalopram, and fluoxetine. A doctor may favor sertraline when breastfeeding is likely because it generally reaches breast milk in low amounts.
Research does not show that every SSRI has the same risk profile. Possible newborn effects after late-pregnancy exposure include temporary jitteriness, feeding problems, sleep changes, or breathing difficulty. These effects usually receive monitoring after birth.
A person should not stop an SSRI suddenly. Stopping can cause withdrawal symptoms and allow depression or anxiety to return. The prescribing clinician and obstetric provider should review the dose, timing, prior response, and pregnancy risks together.
Serotonin-Norepinephrine Reuptake Inhibitors
SNRIs, such as venlafaxine and duloxetine, affect serotonin and norepinephrine. Doctors may consider them when an SSRI did not work, caused difficult side effects, or when the person previously responded well to an SNRI.
Available studies have not shown a clear major birth-defect pattern for these medicines, but research cannot remove all uncertainty. Late-pregnancy use may lead to temporary newborn symptoms, including irritability, tremors, feeding difficulty, or breathing problems.
SNRIs can also raise blood pressure in some patients. The care team may monitor blood pressure, symptoms, and fetal growth when appropriate. The person should avoid changing the dose without medical advice.
Other Antidepressant Options
Other choices may fit specific medical histories. Bupropion may help depression and can support smoking cessation, but it usually does not serve as a first-choice anxiety medicine. Mirtazapine may help depression with poor sleep, nausea, or low appetite, although it can cause drowsiness and weight gain.
Some tricyclic antidepressants, including nortriptyline, have pregnancy-use data and may help when newer medicines fail. They can cause dry mouth, constipation, sleepiness, or heart-related side effects.
Benzodiazepines, such as lorazepam, clonazepam, and alprazolam, require extra caution. Regular or late-pregnancy use may contribute to newborn sedation, breathing problems, or withdrawal. They should not be stopped suddenly after regular use because withdrawal can be dangerous.
Medicines That May Require Extra Caution
Some medicines can help during pregnancy but may carry specific risks for the fetus or newborn. A healthcare professional should review the dose, timing, other medicines, and risks of untreated anxiety or depression before treatment starts or changes.
Benzodiazepines
Benzodiazepines include lorazepam, clonazepam, alprazolam, and diazepam. They can reduce severe anxiety quickly, but pregnancy usually calls for caution because these medicines may cause newborn sedation, poor feeding, breathing problems, or withdrawal symptoms. Higher doses and use near delivery may raise these risks.
They may also cause dependence when taken regularly. A person who has used a benzodiazepine for a long time should not stop suddenly, because withdrawal can include severe anxiety, seizures, and other serious symptoms.
| Concern | Important detail |
|---|---|
| Newborn effects | Sleepiness, weak feeding, breathing problems, or withdrawal |
| Long-term use | May cause physical dependence |
| Stopping treatment | Requires a planned, gradual dose reduction |
| Common approach | Consider other treatments first when suitable |
A clinician may still prescribe one for a serious condition when the expected benefit outweighs the risks. The patient should not start, stop, or change the dose without medical guidance.
Paroxetine
Paroxetine is an SSRI used for depression and several anxiety disorders. Some studies have raised concern about a small increase in certain heart defects when exposure occurs early in pregnancy. Research findings do not always agree, and the absolute risk remains low.
A person who responds well to paroxetine should not switch medicines without medical advice. Changing treatment can cause withdrawal symptoms, return of depression or anxiety, or exposure to a different medicine that may not work as well.
Use late in pregnancy may cause temporary newborn symptoms, such as irritability, tremors, feeding difficulty, or breathing problems. These symptoms often improve with observation and supportive care. The delivery team should know about paroxetine use so they can monitor the newborn.
Mood Stabilizers and Antipsychotics
Mood stabilizers require careful review because risks differ greatly by medicine. Valproate has strong links to birth defects and problems with brain development, so clinicians generally avoid it during pregnancy when safer options can control the condition. Lithium may increase the risk of certain heart defects, especially with early-pregnancy exposure, but it can remain important for preventing severe mood episodes.
Lamotrigine is often considered a lower-risk option for bipolar disorder, although its dose may need adjustment during pregnancy. Antipsychotics such as quetiapine or olanzapine may be used when benefits justify risks, but they can affect weight, blood sugar, and newborn adaptation.
A psychiatrist and obstetric clinician should coordinate treatment. Patients should not stop mood stabilizers or antipsychotics suddenly, because relapse can threaten both the patient and pregnancy.
Safety Considerations by Pregnancy Stage
Medication decisions depend on the pregnancy stage, the specific drug, the dose, and the person’s mental health history. Clinicians weigh possible fetal and newborn effects against the risks of untreated anxiety or depression.
First Trimester Decisions
The first trimester includes early fetal development, so clinicians review medication choices carefully. Some studies link certain medicines with a small increase in specific birth defects, but the risk varies by drug and may also reflect the effects of untreated illness or other health factors.
Stopping an antidepressant suddenly can cause withdrawal symptoms and may trigger a return of depression or anxiety. A clinician may recommend continuing, changing, or adjusting treatment based on the person’s past response, symptom severity, and pregnancy history.
| Medication group | Key first-trimester consideration |
|---|---|
| SSRIs, such as sertraline or fluoxetine | Often considered when treatment benefits outweigh possible risks |
| SNRIs | Require an individual risk–benefit review |
| Bupropion | May be considered for some patients, but evidence is less extensive for certain outcomes |
| Benzodiazepines | Usually avoided or limited because of fetal and newborn concerns |
People should not start, stop, or change a medication without guidance from an obstetric and mental health clinician.
Late-Pregnancy and Newborn Effects
Later in pregnancy, clinicians focus more on newborn adaptation after birth. SSRI and SNRI exposure near delivery can sometimes cause temporary symptoms, such as jitteriness, feeding difficulty, sleep changes, muscle tension, or breathing problems. These symptoms usually receive monitoring and supportive care, but the birth team should know about the medication.
Some antidepressants can also slightly increase the risk of persistent pulmonary hypertension in the newborn, although the absolute risk remains low. Benzodiazepines taken near delivery may cause sedation, weak muscle tone, breathing problems, or withdrawal symptoms.
Clinicians balance these concerns against relapse risk. They may avoid unnecessary dose changes near delivery and arrange newborn observation when medication exposure makes monitoring appropriate. The person should provide a complete medication list to the obstetric and pediatric teams.
Choosing the Right Treatment Plan
A clinician weighs past medication results, illness severity, pregnancy stage, and possible risks to the fetus and newborn. The plan may include therapy, medication, or both, with regular checks for symptom changes and side effects.
Previous Treatment Response
A medication that controlled symptoms before pregnancy may remain the best option. Changing a stable treatment can cause relapse, and untreated severe anxiety or depression can affect sleep, nutrition, prenatal care, and daily function.
The clinician reviews which medicines worked, the dose that helped, side effects, and whether symptoms returned after stopping treatment. She should not stop an antidepressant or anxiety medicine suddenly. Abrupt changes can cause withdrawal symptoms or a return of symptoms.
| Key factor | Why it matters |
|---|---|
| Past benefit | A proven response may support continuing the same medicine. |
| Past side effects | Problems may guide the clinician toward another option. |
| Relapse after stopping | A higher relapse risk may favor continued treatment. |
Therapy, especially cognitive behavioral therapy, may help with mild or moderate symptoms. More serious symptoms may require medication, therapy, or psychiatric care.
Dose Adjustments and Monitoring
Clinicians usually aim for the lowest effective dose, not automatically the lowest possible dose. An ineffective dose may leave symptoms untreated, while unnecessary dose increases can add side effects.
Pregnancy changes how the body processes some medicines. The clinician may adjust the dose during pregnancy or after delivery, based on symptoms, side effects, and the medicine involved. She should report worsening anxiety or depression, severe restlessness, suicidal thoughts, unusual sleep changes, or trouble functioning promptly.
The care team may monitor blood pressure, sleep, appetite, weight, fetal growth when appropriate, and newborn effects near delivery. SSRIs and SNRIs can sometimes cause temporary newborn symptoms, such as jitteriness or feeding difficulty. Benzodiazepines require particular caution because repeated or late-pregnancy use can cause newborn sedation, breathing problems, or withdrawal.
Non-Medication Supports
Psychotherapy can treat anxiety and depression during pregnancy without exposing the fetus to medication. Regular sleep, safe physical activity, and support from trusted people may also reduce symptoms and help a pregnant person manage daily stress.
Psychotherapy
Cognitive behavioral therapy (CBT) helps a person identify distressing thoughts and replace them with more useful responses. It can address worry, low mood, panic, guilt, and fears about pregnancy or childbirth. A therapist may also teach breathing exercises, problem-solving skills, and gradual exposure for specific fears.
Interpersonal therapy (IPT) focuses on relationship changes, grief, conflict, and the shift into parenthood. These concerns often affect mood during pregnancy. A licensed therapist, psychologist, psychiatrist, or trained counselor can provide treatment in person or through telehealth.
People with severe symptoms may need psychotherapy along with medication. Anyone with thoughts of self-harm, harm to others, or an inability to function should contact a health professional immediately or use local emergency services. Evidence on non-medication care is summarized in this systematic review of perinatal mental health treatments.
Sleep, Activity, and Social Support
Poor sleep can worsen anxiety and depression. A consistent bedtime, a dark and quiet room, and limited screens before bed may help. Pregnancy symptoms may require adjustments, so a clinician should address pain, reflux, frequent urination, or possible sleep apnea.
Unless a medical professional advises otherwise, many pregnant people can try gentle activities such as walking, swimming, or prenatal exercise. Activity should stop if warning signs occur, including vaginal bleeding, chest pain, dizziness, severe shortness of breath, painful contractions, or fluid leakage.
Social support also matters. A partner, family member, friend, support group, or prenatal care team can provide practical help with meals, appointments, childcare, and rest. A written plan can identify warning signs, preferred supports, and the clinician to contact if symptoms become harder to manage.
Working With Your Prenatal Care Team
A prenatal care team can compare medication benefits and risks, review other treatments, and create a plan for changes during pregnancy. Urgent symptoms need prompt attention, while early postpartum planning can reduce gaps in care.
When to Seek Urgent Help
A pregnant person should contact a healthcare professional promptly if anxiety or depression prevents eating, sleeping, attending prenatal visits, or taking prescribed medicine. A sudden increase in panic, severe agitation, confusion, or inability to care for basic needs also requires urgent assessment.
Thoughts of suicide, self-harm, harming someone else, or not wanting to live require immediate help. The person should call emergency services or go to the nearest emergency department. In the United States, they can call or text 988 for the Suicide & Crisis Lifeline. They should not stay alone, drive themselves if unsafe, or stop psychiatric medicine without medical guidance.
The prenatal team should know about all medicines, supplements, alcohol, and other substances. A clinician may adjust the dose, change the medicine, add therapy, or arrange a higher level of support. Treatment decisions should consider symptom severity, past responses, pregnancy stage, and the risks of untreated illness.
Planning for Postpartum Care
Pregnancy medication plans should include the weeks after delivery. Before birth, the care team can decide who will manage mental health treatment, when follow-up will occur, and how the plan may change during breastfeeding. The team should also discuss sleep support, therapy, and help with infant care.
A pregnant person should ask about warning signs of postpartum depression, severe anxiety, mania, or psychosis. Hallucinations, extreme confusion, severe sleeplessness, or beliefs that seem disconnected from reality require emergency care. A written plan can list symptoms, emergency contacts, medicines, and trusted support people.
The obstetric and mental health teams should share information with the patient’s permission. Medication changes should happen only with a prescriber’s advice. Stopping an antidepressant or anxiety medicine suddenly can cause withdrawal symptoms or allow symptoms to return.
FAQs
Are anxiety and depression medications safe during pregnancy?
Some medications can be used during pregnancy, but none are risk-free. A healthcare provider weighs the person’s symptoms, medical history, pregnancy stage, and the possible risks of untreated illness.
Which medications are commonly considered?
Selective serotonin reuptake inhibitors (SSRIs), such as sertraline, escitalopram, and fluoxetine, are often considered when medication is needed. The provider may choose a different option based on past treatment and how well the medication works.
Should someone stop medication after becoming pregnant?
They should not stop suddenly or change the dose without medical advice. Sudden changes can cause withdrawal symptoms and may allow anxiety or depression to return.
Are benzodiazepines safe during pregnancy?
Medicines such as alprazolam, diazepam, lorazepam, and clonazepam require special caution. Regular or high-dose use may cause newborn sedation, breathing problems, or withdrawal. A provider may recommend avoiding them or using the lowest dose for the shortest time.
Can untreated anxiety or depression harm pregnancy?
Severe, untreated symptoms can affect sleep, nutrition, daily functioning, and prenatal care. A treatment plan may include therapy, support, lifestyle changes, medication, or a combination of these.
What should someone do before taking a medication?
They should tell the obstetrician and mental health provider about every medicine, supplement, and health condition. They should also seek urgent help for thoughts of self-harm or harm to the baby.
Conclusion
Pregnancy does not automatically rule out treatment for anxiety or depression. Doctors often consider SSRIs, such as sertraline, escitalopram, or fluoxetine, when the expected benefits outweigh possible risks. Research suggests that the chance of serious birth defects remains low, but each medication has its own safety profile.
Benzodiazepines, including lorazepam and clonazepam, require more caution. They may cause newborn sedation, breathing problems, or withdrawal symptoms, especially with regular or late-pregnancy use.
The decision depends on the person’s symptoms, medical history, pregnancy stage, past treatment response, and risk of untreated illness. A doctor may recommend therapy, medication, or both. Pregnant patients should not stop an antidepressant or anxiety medicine suddenly, since withdrawal and returning symptoms can create risks.
A person who is pregnant, planning pregnancy, or breastfeeding should discuss treatment with an obstetrician, psychiatrist, or primary care clinician. The care team can compare options and choose the lowest effective dose while monitoring both the patient and baby.
